Andrea Bassetti of ICIS unpacks trade shifts, recycling policy gaps, and the future of plastics in North America.

It suggests the UK remains a long way from fulfilling Energy Secretary Ed Miliband’s pre-election pledge to cut an average ...

Many patients with metastatic clear cell renal cell carcinoma (ccRCC) are not receiving immune checkpoint inhibitors (ICIs) as first-line therapy, according to a study published in JAMA Network Open.

Panelists discuss how current first-line systemic therapies for advanced hepatocellular carcinoma (HCC) include atezolizumab + bevacizumab and durvalumab + tremelimumab, replacing tyrosine kinase ...

The agent was evaluated in a phase 2a trial that enrolled stage III/IV patients with NSCLC who were refractory to ICIs (n = 33). 2 Among 76 enrolled patients, 46 completed 2 courses of CAN-2409 with ...